WASHINGTON, March 10 (Reuters) - Medtronic Inc missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents ...

Medtronic Percept™ DBS therapy is the only sensing-enabled † DBS system available, allowing a physician to use data from a patient’s brain activity to personalize their treatment. Andy says Medtronic ...

Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. "Our DBS therapy with ...

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...

Medtronic has secured a European approval for a rechargeable version of its deep-brain stimulation implant, allowing for a smaller and thinner neuromodulation device. The CE mark covers the company’s ...

MINNEAPOLIS--(BUSINESS WIRE)-- In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson’s disease, Medtronic DBS Therapy was shown to improve motor function for up to ...

The technology is designed to adjust therapy in real time based on a patient’s brain activity, potentially improving symptom control, according to a Feb. 24 news release from the company. The ...

The US FDA approves Medtronic’s rechargeable deep brain stimulation for patients with movement disorders and epilepsy. The US Food and Drug Administration (FDA) has approved a rechargeable deep brain ...

MERRIFIELD, Minn. — Bruce Lunde has never let his age stop him from staying active, so when Parkinson's Disease threatened to slow him down at the age of 81, he decided to take action. Lunde recently ...

Keith Krehbiel lived with Parkinson’s disease for nearly 25 years before agreeing to try a brain implant that might alleviate his symptoms. He had long been reluctant to submit to the surgery. “It was ...